Expand / Collapse search
☰
Flood Warning
from SAT 2:41 PM MST until MON 8:00 AM MST, Maricopa County
5
Flood Warning
from SAT 3:52 PM MST until MON 7:45 AM MST, Maricopa County
Flood Watch
from SAT 11:00 PM MST until MON 5:00 AM MST, Eastern Cochise County below 5000 ft including Douglas/Wilcox, Upper Gila River and Aravaipa Valleys including Clifton/Safford, Southeast Pinal County including Kearny/Mammoth/Oracle, Western Pima County including Ajo/Organ Pipe Cactus National Monument, Dragoon/Mule/Huachuca and Santa Rita Mountains including Bisbee/Canelo Hills/Madera Canyon, Tucson Metro Area including Tucson/Green Valley/Marana/Vail, Tohono O'odham Nation including Sells, Baboquivari Mountains including Kitt Peak, Upper San Pedro River Valley including Sierra Vista/Benson, Chiricahua Mountains including Chiricahua National Monument, Galiuro and Pinaleno Mountains including Mount Graham, Santa Catalina and Rincon Mountains including Mount Lemmon/Summerhaven, White Mountains of Graham and Greenlee Counties including Hannagan Meadow, South Central Pinal County including Eloy/Picacho Peak State Park, Upper Santa Cruz River and Altar Valleys including Nogales, Northwest Plateau, Lake Havasu and Fort Mohave, North Phoenix/Glendale, Aguila Valley, Mazatzal Mountains, Tonopah Desert, Gila Bend, San Carlos, East Valley, Northwest Pinal County, Northwest Valley, Southeast Valley/Queen Creek, Globe/Miami, Deer Valley, Fountain Hills/East Mesa, Apache Junction/Gold Canyon, Buckeye/Avondale, Tonto Basin, Rio Verde/Salt River, South Mountain/Ahwatukee, Dripping Springs, Southeast Gila County, Pinal/Superstition Mountains, Scottsdale/Paradise Valley, New River Mesa, Sonoran Desert Natl Monument, West Pinal County, Superior, Cave Creek/New River, Central Phoenix, Yavapai County Mountains, Little Colorado River Valley in Navajo County, Western Mogollon Rim, Coconino Plateau, Yavapai County Valleys and Basins, Oak Creek and Sycamore Canyons, Grand Canyon Country, Little Colorado River Valley in Coconino County, Marble and Glen Canyons, Northern Gila County, White Mountains, Kaibab Plateau, Eastern Mogollon Rim, Little Colorado River Valley in Apache County
Flood Watch
from SUN 12:00 AM MDT until MON 5:00 AM MST, Chinle Valley, Chuska Mountains and Defiance Plateau, Northeast Plateaus and Mesas South of Hwy 264, Black Mesa Area, Northeast Plateaus and Mesas Hwy 264 Northward
Flood Advisory
from SAT 5:49 PM MST until SAT 8:45 PM MST, Mohave County

Veozah, a new menopause drug for hot flashes, gets FDA approval

By AP Staff
Associated Press
Health Care
Published May 13, 2023 7:25 AM MST
Published May 13, 2023 7:25 AM MST
Over-the-counter Narcan approved for sale by the FDA | LiveNOW from FOX
Over-the-counter Narcan approved for sale by the FDA | LiveNOW from FOX

Over-the-counter Narcan approved for sale by the FDA | LiveNOW from FOX

The U.S. Food and Drug Administration approved selling overdose drug naloxone over the counter. Dr. Peter Chin-Hong from University of California, San Francisco spoke with LiveNOW's Andrew Craft about the FDA's decision.

U.S. health regulators on Friday approved a new type of drug for women dealing with uncomfortable hot flashes caused by menopause.

The Food and Drug Administration approved the once-a-day pill from Astellas Pharma to treat moderate-to-severe symptoms, which can include sweating, flushing and chills.

Astellas' drug, Veozah, uses a new approach, targeting brain connections that help control body temperature. The FDA said the medication will provide "an additional safe and effective treatment option for women," in a statement.

READ MORE: FDA approves over-the-counter Narcan: Here's what it means

More than 80% of women experience hot flashes during menopause, the FDA noted, as the body gradually produces lower levels of reproductive hormones between the ages of 45 and 55.

5293e748-

Veozah tablets (Astellas Pharma)

The most common treatment consists of hormonal pills aimed at boosting levels of estrogen and progestin. But the treatment isn't appropriate for some women, including those with a history of stroke, blood clots, heart attack and other health conditions. Large studies have found that the hormones can increase the chances of those problems reoccurring, although the risks vary based on a number of individual factors.

READ MORE: FDA approves robotic bassinet to help keep babies sleeping on their backs

The new pill is not a hormone. It carries an FDA warning about potential liver damage. Women will need to be screened for liver damage or infection before getting a prescription, then get a blood test every three months for nine months to monitor for safety problems, according to the FDA label.

Astellas said the drug will cost $550 for a one-month supply. That's the price before insurance coverage and other discounts typically negotiated by insurers and pharmacy benefit managers.

Health CareHealthHealthU.S.News